This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

IBM Research Unveils Two New Watson Related Projects From Cleveland Clinic Collaboration

CLEVELAND, Oct. 15, 2013 /PRNewswire/ -- IBM Research (NYSE: IBM) today unveiled two new Watson-related cognitive technologies that are expected to help physicians make more informed and accurate decisions faster and to cull new insights from electronic medical records (EMR).

The projects known as "WatsonPaths" and "Watson EMR Assistant" are the result of a year-long research collaboration with faculty, physicians and students at Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. Both are key projects that will create technologies that can be leveraged by Watson to advance the technology in the domain of medicine. 

With the WatsonPaths project, IBM scientists have trained the system to interact with medical domain experts in a way that's more natural for them, enabling the user to more easily understand the structured and unstructured data sources the system consulted and the path it took in offering an option. The Watson EMR Assistant project aims to enable physicians to uncover key information from patients' medical records in order to help improve the quality and efficiency of care.

"On Jeopardy! it was not necessarily critical to know how Watson arrived at its answer. But doctors or domain experts in any field will want to understand what information sources Watson consulted, what logic it applied and what inferences it made in arriving at a recommendation," said Eric Brown, IBM Research Director of Watson Technologies. "Through our research collaboration with Cleveland Clinic, we've been able to significantly advance technologies that Watson can leverage to handle more and more complex problems in real time and partner with medical experts in a much more intuitive fashion. These are breakthrough technologies intended to assist future versions of Watson products."

"WatsonPaths is designed to augment the problem-based learning methods that Cleveland Clinic medical students employ in the classroom. The vision is for WatsonPaths to act as a useful guide for students to arrive at the most likely and least likely answers to real clinical problems, but in a classroom setting," said J. Eric Jelovsek, MD, MMEd, Director of the Cleveland Clinic Multidisciplinary Simulation Center. "Of course, it is also easy to visualize how this type of technology could eventually be a tool for physicians to use in real-time clinical scenarios – a powerful guiding reference to consult when diagnosing and identifying the best treatment options."

Using WatsonPaths to support clinical reasoning

WatsonPaths explores a complex scenario and draws conclusions much like people do in real life. When presented with a medical case, WatsonPaths extracts statements based on the knowledge it has learned as a result of being trained by medical doctors and from medical literature.  

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 16,895.06 +104.87 0.62%
S&P 500 1,992.15 +12.23 0.62%
NASDAQ 4,780.6930 +32.3320 0.68%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs